- Status:
- Red
- Decision Date:
- November 2022
Comments
RED:
- NICE TA832 - Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids. (Decision date - November 2022)
- Treatment of adults with advanced hormone-sensitive prostate cancer. NHSE commissioned. (Decision date - March 2023)
Red Drug Classifications
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again